Old Web
English
Sign In
Acemap
>
Paper
>
P2.01-96 Response to Anti-HER2 Afatinib in a Case of Invasive Pulmonary Mucinous Adenocarcinoma with a SLC3A2-NRG1 Fusion
P2.01-96 Response to Anti-HER2 Afatinib in a Case of Invasive Pulmonary Mucinous Adenocarcinoma with a SLC3A2-NRG1 Fusion
2019
F. Magne
Véronique Haddad
L. Odier
Michaël Duruisseaux
S. Blandin
C. Dussopt
Lionel Falchero
D. Arpin
Keywords:
Adenocarcinoma
Oncology
Pathology
Afatinib
Internal medicine
Medicine
Cancer research
anti her2
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]